Addressing the medicines access challenge through balance, evidence, collaboration and transparency: key take-away lessons of the 4th PPRI Conference

Southern Med Review

article

Vogler, Sabine¹  Zimmermann, Nina¹  Babar, Zaheer-Ud-Din²  Busse, Reinhard³  Espin, Jaime⁴  Mantel-Teeuwisse, Aukje K.⁵  Panteli, Dimitra³  Suleman, Fatima⁶  Wirtz, Veronika J.⁷ 

[1] WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Pharmacoeconomics Department, Gesundheit Österreich GmbH (GÖG/Austrian National Public Health Institute);University of Huddersfield;Department of Health Care Management, Technische Universität Berlin;Andalusian School of Public Health (EASP);Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University;WHO Collaborating Centre for Pharmaceutical Policy and Evidence Based Practice, Discipline of Pharmaceutical Sciences, School of Health Sciences, University of KwaZulu-Natal (Westville Campus);WHO Collaborating Centre in Pharmaceutical Policy, Department of Global Health, Boston University School of Public Health

关键词: Access to medicines;    Policy options;    Affordability;    Pricing policies;    Reimbursement;    Medicine prices;    Debate;    Collaboration;   

DOI  :  10.1186/s40545-021-00300-3

学科分类：药理学

来源: BioMed Central

【 摘 要 】

The 4th PPRI Conference, held in Vienna in October 2019, addressed issues related to equitable and affordable access to medicines. A multi-stakeholder audience from around the globe discussed solutions and best practice models for current challenges such as high-priced medicines, limitations of current pricing and reimbursement policies and tight budgets for health technologies. A multi-faceted approach (so-called balance, evidence, collaboration and transparency/BECT strategy) was also discussed. This includes an improved balance of different interests and policy areas, generation of relevant evidence, collaboration between countries and stakeholders, and transparency, and was considered as the most promising pathway for the future.

【 授权许可】

Unknown